Trials / Completed
CompletedNCT01489735
The Use of International GerdQ Questionnaire
Observational Non-interventional Study on the Use of International GerdQ Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease in the Russian Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There are three main directions for use GerdQ in practice. First of all, GerdQ can be used to diagnose GERD with an accuracy comparable to the accuracy of diagnosis of GERD by the specialist (gastroenterologist). Using GerdQ can evaluate the impact of disease on the patient's life and help in choosing treatment of GERD, as well as direct assessment of treatment efficacy. In connection with mentioned above, this study is devoted to the estimation of possibility to use GerdQ in routine practice of Russian physicians.
Detailed description
Observational non-interventional study on the use of international GerdQ questionnaire for the diagnosis of gastroesophageal reflux disease in the Russian practice
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2011-12-12
- Last updated
- 2013-01-28
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01489735. Inclusion in this directory is not an endorsement.